Publication Date:
2002
abstract:
The receptor tyrosine kinase RET, with a known role in embryonic
development and in human pathologies, is alternatively spliced to
yield at least two functional isoforms, which differ only in their carboxyl
terminal. Enigma protein is a member of the PDZ-LIM family and is
known to interact with the short isoform of RET/PTC2, a chimeric
oncoprotein isolated from papillary thyroid carcinoma. Here, we show
that Enigma also interacts in intact cells with the short isoform of
RET-wt and of its pathologic mutants associated to MEN2
syndromes, RET-C634R and RET-M918T. In contrast, Enigma binds
all the corresponding RET long isoforms very poorly and colocalizes
with short but not long RET/PTC2 isoforms. The RET docking
tyrosine for Enigma is the last but one before the divergence between
the two isoforms and we demonstrated that short-isoform-specific
amino acid residues +2 to +4 to this tyrosine are required for the
interaction of RET/PTC2 with Enigma.
Iris type:
01.01 Articolo in rivista
Published in: